Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
ClinicalTrials.gov study NCT06781281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC
ClinicalTrials.gov study NCT05000736. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fracture Healing Assessed by HR-pQCT After Administration of Calcium and Vitamin D
ClinicalTrials.gov study NCT02889237. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota
ClinicalTrials.gov study NCT06802809. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or
ClinicalTrials.gov study NCT05646862. IPD Sharing: YES. Countries: 18. Publications: 0.
18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT06655545. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
ClinicalTrials.gov study NCT04827719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT06612203. IPD Sharing: NO. Countries: 2. Publications: 0.
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative
ClinicalTrials.gov study NCT07330544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
ClinicalTrials.gov study NCT04895358. IPD Sharing: YES. Countries: 31. Publications: 0.
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
ClinicalTrials.gov study NCT03854903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Validation of Molecular Triage in HR-HPV Positive Women
ClinicalTrials.gov study NCT05193669. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
ClinicalTrials.gov study NCT07229417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
ClinicalTrials.gov study NCT06843720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
ClinicalTrials.gov study NCT04232917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
ClinicalTrials.gov study NCT06619704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Examining Perceptions of the 24-Hr Movement Guidelines
ClinicalTrials.gov study NCT04281615. IPD Sharing: NO. Countries: 1. Publications: 0.
To Compare the Efficacy & Safety of Ultra-Slow (24 hr) Low Dose (25 mg) Infusion of Alteplase Over Slow (24hr) Infusion of Streptokinase in Mechanical Prosthetic Valve Thrombosis
ClinicalTrials.gov study NCT07360717. IPD Sharing: NO. Countries: 1. Publications: 0.
Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II a
ClinicalTrials.gov study NCT06905301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
COMPARISON OF CORNEAL MEASUREMENTS IN NORMAL AND KERATOCONUS EYES USING ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY AND PENTACAM HR TOPOGRAPHER
ClinicalTrials.gov study NCT04462991. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.